CoraLite® Plus 488-conjugated human IgM Monoclonal antibody
human IgM Monoclonal Antibody for IF-P
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
WB, IF-P
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
2D10B10
Cat no : CL488-66484
Synonyms
Validation Data Gallery
Tested Applications
Positive IF-P detected in | human appendicitis tissue, human tonsillitis tissue |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
WB | See 1 publications below |
IF | See 1 publications below |
Product Information
CL488-66484 targets human IgM in WB, IF-P applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | human IgM fusion protein Ag1459 相同性解析による交差性が予測される生物種 |
Full Name | immunoglobulin heavy constant mu |
Calculated molecular weight | 69 kDa |
Observed molecular weight | 75 kDa |
GenBank accession number | BC009851 |
Gene symbol | IGHM |
Gene ID (NCBI) | 3507 |
RRID | AB_2883344 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 human IgM antibody CL488-66484 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Oncol Lett Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells. | ||
Rapid Commun Mass Spectrom iTRAQ-based quantitative proteomic analysis of immune thrombocytopenia patients before and after Qishunbaolier treatment. |